Replacing the NCCN's Blocks with Wheels: How Should Consideration of Societal Spending be Incorporated into Oncology Practice?
Pharmacoeconomics
.
2020 Jul;38(7):729-731.
doi: 10.1007/s40273-020-00920-8.
Authors
Audrey A Tran
1
2
,
Vinay Prasad
3
4
5
Affiliations
1
Oregon Health and Science University School of Medicine, 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA.
2
Division of Hematology Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
3
Oregon Health and Science University School of Medicine, 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA. prasad@ohsu.edu.
4
Division of Hematology Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. prasad@ohsu.edu.
5
Department of Public Health and Preventive Medicine, Oregon Health and Science University, Portland, OR, USA. prasad@ohsu.edu.
PMID:
32328981
DOI:
10.1007/s40273-020-00920-8
No abstract available
Publication types
Comment
MeSH terms
Costs and Cost Analysis
Data Collection
Humans
Neoplasms*